Skip to content
Back to Investors
Ascension

Ascension

Venture Capital

Ascension Ventures is a venture capital firm that led the pre-seed funding round for Voxmind.


Recent investments

Seed
£3.3M

The financing round was led by Octopus Ventures and will support a major recruitment drive.

"Foodsteps has been helping dozens of the UK’s most ambitious food companies to reduce their environmental footprint through our farm to fork data platform and labels. However we need to do so much more. This funding will help us bring in the brightest minds in data and technology to accelerate our work. We’re also looking for food businesses and partners that are hungry to accelerate change and reduce their environmental impacts. Our commitment is to be a force for transparency, collaboration and ambition in the drive to fix our food system."
— Anya Doherty, CEO and Founder
Seed
£1.8M

The seed round was led by 1818 Venture Capital to support product and engineering recruitment.

"We met some fathers in a small town outside Rochdale. Hearing their experience of transport poverty – they were looking for work, there were opportunities just a 15-minute drive away, but they couldn’t drive and there was no viable way to get there by public transport – was mind-blowing."
— Alex Shapland-Howes, Co-founder and CEO
Pre-Seed
$2.4M

The pre-seed round was led by CapitalT with backing from a range of institutional investors and angel backers.

"We are so excited to continue to drive circularity in the sector in a new way – through the repair and tailoring of our clothes. Having such a brilliant roster of investors onboard to enable us to have true scale and impact. Here’s to a future of clothes that are made to fit and made to last."
— Josephine Philips, Founder & CEO
Seed
£2.5M

Future Planet Capital led the round as the med-tech startup prepares for international market launches.

"This funding allows AMLo to embark on the next step of our journey with the resources to potentially relieve countless people with early-stage melanoma from the anxiety and follow-up burden that should be reserved for those with higher risk disease. I am delighted to welcome several new investors, and especially to see such strong additional commitment from our previous partners. Our levelling up from an academic spin-out to commercial success is critical to ensure we have the resources to further drive innovation in medical devices across our markets."
— Marie Labus, CEO and Co-founder
Other
$8.2M

Octopus Ventures led the round as Contingent looks to scale its supply chain risk and transparency software.

"There is an ever-increasing amount of focus on risk management within supply chains and Contingent provides us with a platform to capture the key areas of risk. As we put more of a spotlight on ESG, the team at Contingent is continuously improving the platform, its features and coverage, which supports us as we continue to grow as a business,"
— Steven McGeagh